Intelligent Bio Solutions Inc. (INBS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-36.70 et chiffre d'affaires de $0.00B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-6.38 vs est $-36.70 (dépassé +82.6%). 2025: réel $-20.00 vs est $-12.50 (manqué -60%). Précision des analystes: 0%.
Estimations du BPA — INBS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$6.38
vs Est –$36.70
▲ 475.2% off
2025
Actual –$20.00
vs Est –$12.50
▼ 37.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Estimations du CA — INBS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.004B
▼ 35.0% off
2025
Actual $0.003B
vs Est $0.012B
▼ 280.0% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
Les autres consultent aussi
